# Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage

> **NCT03870503** · NA · COMPLETED · sponsor: **Aswan University Hospital** · enrollment: 135 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** oxytocin
- **DRUG:** oxytocin plus misoprostol
- **DRUG:** Carbetocin

## Key facts

- **NCT ID:** NCT03870503
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-08-01
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03870503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03870503, "Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03870503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*